SCHEMBL29655217

SCHEMBL29655217

Nc1ccc(-c2cccc(F)c2F)cc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PGR P06401 2/20 0.44
BACE1 P56817 3/20 0.40
APP P05067 1/20 0.40
DYRK1A Q13627 2/20 0.39
KCNH2 Q12809 2/20 0.39
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
PIM1 P11309 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
SCN9A Q15858 1/20 0.37
MAP4K4 O95819 1/20 0.37
CTSD P07339 1/20 0.37
BACE2 Q9Y5Z0 1/20 0.37
CNR2 P34972 1/20 0.37
PTPRC P08575 1/20 0.37
PTPN1 P18031 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29655190 0.84 BACE1 (0.53) MEN1KMT2ATDP1PGRBACE1
SCHEMBL29655115 0.84 BACE1 (0.53) MEN1KMT2ATDP1PGRBACE1
SCHEMBL5952352 0.84 BACE1 (0.53) MEN1KMT2ATDP1PGRBACE1
SCHEMBL26832646 0.84 ALDH1A1 (0.50) MEN1KMT2APGRBACE1APP
SCHEMBL5843815 0.84 CYP3A4 (0.53) MEN1KMT2APGRBACE1APP
Ammonia Solution, Strong SCHEMBL5953223 0.82 BACE1 (0.51) MEN1KMT2ATDP1PGRBACE1
SCHEMBL27787920 0.82 TDP1 (0.50) MEN1KMT2ATDP1KCNH2ALOX5AP
SCHEMBL13263254 0.79 WDR5 (0.47) PGRBACE1APPDYRK1APIM1
SCHEMBL19452779 0.78 PGR (0.44) PGRBACE1APPDYRK1AALOX5AP
SCHEMBL20486024 0.78 TAAR1 (0.45) TDP1PGRBACE1APPDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed